91 related articles for article (PubMed ID: 33458427)
1. Prostate-specific membrane antigen positron emission tomography/computed tomography as a potential tool to assess and guide salivary gland irradiation.
Valstar MH; Owers EC; Al-Mamgani A; Smeele LE; van de Kamer JB; Sonke JJ; Vogel WV
Phys Imaging Radiat Oncol; 2019 Jan; 9():65-68. PubMed ID: 33458427
[TBL] [Abstract][Full Text] [Related]
2. PSMA PET/CT Identifies Intrapatient Variation in Salivary Gland Toxicity From Iodine-131 Therapy.
Mohan V; Vogel WV; Valk GD; de Boer JP; Lam MGEH; de Keizer B
Mol Imaging; 2020; 19():1536012120934992. PubMed ID: 32619138
[TBL] [Abstract][Full Text] [Related]
3. Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT.
Klein Nulent TJW; Valstar MH; de Keizer B; Willems SM; Smit LA; Al-Mamgani A; Smeele LE; van Es RJJ; de Bree R; Vogel WV
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):478-486. PubMed ID: 29523427
[TBL] [Abstract][Full Text] [Related]
4. Dose response modelling of secretory cell loss in salivary glands using PSMA PET.
Mohan V; Bruin NM; Steenbakkers RJHM; Noordzij W; Terhaard CHJ; de Keizer B; Al-Mamgani A; van de Kamer JB; Sonke JJ; Vogel WV
Radiother Oncol; 2022 Dec; 177():164-171. PubMed ID: 36368471
[TBL] [Abstract][Full Text] [Related]
5. PSMA PET/CT as a predictive tool for subregional importance estimates in the parotid gland.
Sample C; Rahmim A; Benard F; Wu J; Clark H
Biomed Phys Eng Express; 2024 Feb; 10(2):. PubMed ID: 38271732
[No Abstract] [Full Text] [Related]
6. Isolated aplasia of submandibular salivary gland and contralateral prominence of submandibular and sublingual salivary glands incidentally found on
Yousefi-Koma A; Ahmadi R; Gorzi SK; Shiravand Y; Qutbi M
World J Nucl Med; 2020; 19(3):322-323. PubMed ID: 33354200
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8.
von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
[TBL] [Abstract][Full Text] [Related]
9. Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer.
Bussels B; Maes A; Flamen P; Lambin P; Erven K; Hermans R; Nuyts S; Weltens C; Cecere S; Lesaffre E; Van den Bogaert W
Radiother Oncol; 2004 Dec; 73(3):297-306. PubMed ID: 15588874
[TBL] [Abstract][Full Text] [Related]
10. 11C-methionine PET, a novel method for measuring regional salivary gland function after radiotherapy of head and neck cancer.
Buus S; Grau C; Munk OL; Bender D; Jensen K; Keiding S
Radiother Oncol; 2004 Dec; 73(3):289-96. PubMed ID: 15588873
[TBL] [Abstract][Full Text] [Related]
11. [Is there a new salivary gland? - Rather not!].
Guntinas-Lichius O; Ihrler S; Freesmeyer M; Gühne F; Kluge R; Bräuer L; Iro H; Paulsen F; Dietz A; Bechmann I
Laryngorhinootologie; 2021 Jan; 100(1):12-14. PubMed ID: 33197955
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, Predictive Factors, and Prediction Nomograms for
Rauscher I; Düwel C; Haller B; Rischpler C; Heck MM; Gschwend JE; Schwaiger M; Maurer T; Eiber M
Eur Urol; 2018 May; 73(5):656-661. PubMed ID: 29358059
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of
Albisinni S; Artigas C; Aoun F; Biaou I; Grosman J; Gil T; Hawaux E; Limani K; Otte FX; Peltier A; Sideris S; Sirtaine N; Flamen P; van Velthoven R
BJU Int; 2017 Aug; 120(2):197-203. PubMed ID: 27981732
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature.
Ong WL; Koh TL; Lim Joon D; Chao M; Farrugia B; Lau E; Khoo V; Lawrentschuk N; Bolton D; Foroudi F
BJU Int; 2019 Nov; 124 Suppl 1():19-30. PubMed ID: 31507035
[TBL] [Abstract][Full Text] [Related]
15. Initial experience of Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography imaging in evaluation of biochemical recurrence in prostate cancer patients.
Natarajan A; Agrawal A; Murthy V; Bakshi G; Joshi A; Purandare N; Shah S; Puranik A; Rangarajan V
World J Nucl Med; 2019; 18(3):244-250. PubMed ID: 31516367
[TBL] [Abstract][Full Text] [Related]
16. Development of a CT-Based Auto-Segmentation Model for Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography-Delineated Tubarial Glands.
Sample C; Jung N; Rahmim A; Uribe C; Clark H
Cureus; 2022 Nov; 14(11):e31060. PubMed ID: 36475225
[TBL] [Abstract][Full Text] [Related]
17. Impact of
Soeda F; Watabe T; Naka S; Liu Y; Horitsugi G; Neels OC; Kopka K; Tatsumi M; Shimosegawa E; Giesel FL; Hatazawa J
J Nucl Med; 2019 Nov; 60(11):1594-1599. PubMed ID: 30902876
[TBL] [Abstract][Full Text] [Related]
18. Gallium-68-prostate-specific membrane antigen (
van Leeuwen PJ; Donswijk M; Nandurkar R; Stricker P; Ho B; Heijmink S; Wit EMK; Tillier C; van Muilenkom E; Nguyen Q; van der Poel HG; Emmett L
BJU Int; 2019 Jul; 124(1):62-68. PubMed ID: 30074667
[TBL] [Abstract][Full Text] [Related]
19.
Oliveira JM; Gomes C; Faria DB; Vieira TS; Silva FA; Vale J; Pimentel FL
World J Nucl Med; 2017; 16(1):3-7. PubMed ID: 28217012
[TBL] [Abstract][Full Text] [Related]
20. Patterns of relapse as determined by
Henkenberens C; Derlin T; Bengel FM; Ross TL; Wester HJ; Hueper K; Kuczyk MA; Christiansen H; von Klot CA
Strahlenther Onkol; 2018 Apr; 194(4):303-310. PubMed ID: 29134231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
